Answers are grounded in this paper and cite their sources.
Dual-SRD5A inhibition with dutasteride is associated with increased intrahepatic lipid accumulation.
No takes yet. Share an insight, caveat, or question.
Hazlehurst et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: